Chemical activators of F-box and WD-40 domain protein 27 employ various cellular signaling pathways to initiate its phosphorylation and subsequent activation. Phorbol 12-myristate 13-acetate (PMA) specifically targets protein kinase C (PKC), which can directly phosphorylate F-box and WD-40 domain protein 27. Similarly, forskolin works by elevating intracellular cAMP levels, thereby activating protein kinase A (PKA), which also serves to phosphorylate F-box and WD-40 domain protein 27. Ionomycin functions by increasing intracellular calcium concentrations, which activates calcium/calmodulin-dependent protein kinases (CaMKs), and these kinases are capable of phosphorylating F-box and WD-40 domain protein 27 as well. Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing a rise in cytosolic calcium levels that similarly activate CaMKs and lead to the phosphorylation of F-box and WD-40 domain protein 27.
Other chemical activators operate through different mechanisms but achieve the same end of phosphorylating and activating F-box and WD-40 domain protein 27. Anisomycin initiates a stress response that activates stress-activated protein kinases (SAPKs), such as JNK, which in turn can phosphorylate F-box and WD-40 domain protein 27. Conversely, okadaic acid inhibits protein phosphatases, which normally dephosphorylate proteins, thereby maintaining F-box and WD-40 domain protein 27 in a phosphorylated, active state. In a somewhat similar vein, calyculin A also inhibits protein phosphatases leading to sustained phosphorylation of F-box and WD-40 domain protein 27. Meanwhile, staurosporine, at low concentrations, can activate certain kinases that may phosphorylate F-box and WD-40 domain protein 27. Epigallocatechin gallate (EGCG) inhibits some protein kinases, which may lead to the activation of alternative kinases capable of phosphorylating F-box and WD-40 domain protein 27. Sphingosine and bisindolylmaleimide I can activate kinase cascades potentially resulting in the phosphorylation of F-box and WD-40 domain protein 27. Lastly, dibutyryl-cAMP, a cAMP analog, activates PKA, further contributing to the phosphorylation landscape that regulates the activity of F-box and WD-40 domain protein 27.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which in turn can phosphorylate F-box and WD-40 domain protein 27, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, activating calcium/calmodulin-dependent protein kinases (CaMKs), which can directly phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to activation of CaMKs that can phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin induces stress responses that activate stress-activated protein kinases (SAPKs), such as JNK, which can phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases, maintaining proteins in a phosphorylated state, which includes keeping F-box and WD-40 domain protein 27 in an active form through continuous phosphorylation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
At low concentrations, Staurosporine can paradoxically activate certain kinases, which may include kinases that phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits certain protein kinases, possibly leading to the compensatory activation of other kinases that may phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine can activate kinase cascades that lead to the phosphorylation and activation of downstream targets, including potentially F-box and WD-40 domain protein 27. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, while primarily a PKC inhibitor, may cause the activation of alternative pathways that could phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA, which in turn can phosphorylate and activate F-box and WD-40 domain protein 27. | ||||||